A Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 26, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

October 31, 2025

Conditions
Colorectal CancerBowel Cancer
Interventions
DRUG

Artesunate 200mg

Artesunate 200mg PO OD for 14 days prior to colorectal resection surgery

DRUG

Placebo

Matched placebo PO OD for 14 days prior to colorectal resection surgery

Trial Locations (8)

ME7 5NY

COMPLETED

Medway Maritime Hospital, Gillingham

ME16 9QQ

COMPLETED

Kent Oncology Centre, Maidstone Hospital, Maidstone

Unknown

RECRUITING

Barking, Havering and Redbridge University Hospitals NHS Trust, Barking

RECRUITING

Ashford & St Peters Hospital NHS Foundation Trust, Chertsey

RECRUITING

Shrewsbury and Telford Hospital NHS Trust, Shrewsbury

DE22 3NE

RECRUITING

University Hospitals of Derby and Burton NHS Foundation Trust, Derby

SW17 0RE

ACTIVE_NOT_RECRUITING

St George's University Hospitals NHS Fundation Trust, London

NR4 7UY

RECRUITING

Norfolk & Norwich University Hospitlas NHS FT, Norwich

All Listed Sponsors
lead

St George's, University of London

OTHER